Substance P targets sympathetic control neurons in the paraventricular nucleus

Circulation Research

Volumn 100, Issue 11, 2007, Pages 1650-1658

  Womack, Matthew D ^a   Morris, Richard ^a   Gent, Thomas C ^a   Barrett Jolley, Richard ^a  

^a UNIVERSITY OF LIVERPOOL   (United Kingdom)

Author keywords

Cardiovascular control; GABA; Substance P

Indexed keywords

4 AMINOBUTYRIC ACID; 4 AMINOBUTYRIC ACID A RECEPTOR; NEUROKININ 1 RECEPTOR; NEUROKININ 2 RECEPTOR; NEUROKININ 2 RECEPTOR AGONIST; NEUROKININ 2 RECEPTOR ANTAGONIST; NEUROKININ 3 RECEPTOR AGONIST; NEUROKININ 3 RECEPTOR ANTAGONIST; PHORBOL 13 ACETATE 12 MYRISTATE; PROTEIN KINASE C; SUBSTANCE P; TACHYKININ;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BLOOD PRESSURE; BRAIN SLICE; CARDIOVASCULAR SYSTEM; CONTROLLED STUDY; HEART RATE; IN VITRO STUDY; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN LOCALIZATION; PROTEIN PROTEIN INTERACTION; RAT; SYMPATHETIC NERVE CELL; THALAMUS MIDLINE NUCLEUS;

ANIMALS; BLOOD PRESSURE; ENZYME ACTIVATORS; ENZYME INHIBITORS; GAMMA-AMINOBUTYRIC ACID; HEART RATE; KIDNEY; MALE; NEURAL INHIBITION; NEURONS; ORGAN CULTURE TECHNIQUES; PARAVENTRICULAR HYPOTHALAMIC NUCLEUS; PATCH-CLAMP TECHNIQUES; PROTEIN KINASE C; QUINUCLIDINES; RATS; RATS, WISTAR; RECEPTORS, GABA-A; RECEPTORS, NEUROKININ-1; SUBSTANCE P; SYMPATHETIC NERVOUS SYSTEM;

EID: 34250170490     PISSN: 00097330     EISSN: None     Source Type: Journal    
DOI: 10.1161/CIRCRESAHA.107.153494     Document Type: Article

References (67)

1. Coote JH. Landmarks in understanding the central nervous control of the cardiovascular system. Exp Physiol. 2007;92:3-18.
2. Koutcherov Y, Mai JK, Ashwell KWS, Paxinos G. Organization of the human paraventricular nucleus. J Comp Neurol. 2000;423:299-318.
3. Loewy AD. Descending pathways to sympathetic and parasympathetic preganglionic neurons. J Auton Nerv Syst. 1981;3:265-275.
4. Hosoya Y, Sugiura Y, Okado N, Loewy AD, Kohno K. Descending input from the hypothalamic paraventricular nucleus to sympathetic preganglionic neurons in the rat. Exp Brain Res. 1991;85:10-20.
5. Loewy AD. Forebrain nuclei involved in autonomic control. Prog Brain Res. 1991;87:253-268.
6. Swanson LW, Kuypers HG. The paraventricular nucleus of the hypothalamus: cytoarchitectonic subdivisions and organization of projections to the pituitary, dorsal vagal complex, and spinal cord as demonstrated by retrograde fluorescence double-labeling methods. J Comp Neurol. 1980;194:555-570.
7. Lovick TA, Malpas S, Mahony MT. Renal vasodilatation in response to acute volume load is attenuated following lesions of parvocellular neurones in the paraventricular nucleus in rats. J Auton Nerv Syst. 1993;43:247-256.
8. Pyner S, Coote JH. Identification of branching paraventricular neurons of the hypothalamus that project to the rostroventrolateral medulla and spinal cord. Neurosci. 2000;100:549-556.
9. Shafton AD, Ryan A, Badoer E. Neurons in the hypothalamic paraventricular nucleus send collaterals to the spinal cord and to the rostral ventrolateral medulla in the rat. Brain Res. 1998;801:239-243.
10. Cui LN, Coderre E, Renaud LP. Glutamate and GABA mediate supra-chiasmatic nucleus inputs to spinal- projecting paraventricular neurons. Am J Physiol Regul Integ Comp Physiol. 2001;281:R1283-R1289.
11. Jansen AS, Nguyen XV, Karpitskiy V, Mettenleiter TC, Loewy AD. Central command neurons of the sympathetic nervous system: basis of the fight-or-flight response. Science. 1995;270:644-646.
12. Ferguson DW, Berg WJ, Sanders JS. Clinical and hemodynamic correlates of sympathetic-nerve activity in normal humans and patients with heart-failure - evidence from direct microneurographic recordings. J Am Coll Cardiol. 1990;16:1125-1134.
13. Patel KP Role of Paraventricular Nucleus in Mediating Sympathetic Outflow in Heart Failure. Heart Fail Rev. 2000;V5:73-86.
14. Vahid-Ansari F, Leenen FHH. Pattern of neuronal activation in rats with CHF after myocardial infarction. Am J Physiol Heart Circ Physiol. 1998;44:H2140-H2146.
15. Zhang K, Li YF, Patel KP. Reduced endogenous GABA-mediated inhibition in the PVN on renal nerve discharge in rats with heart failure. Am J Physiol Regul Integ Comp Physiol. 2002;282:R1006-R1015.
16. Li YF, Patel KP. Paraventricular nucleus of the hypothalamus and elevated sympathetic activity in heart failure: the altered inhibitory mechanisms. Acta Physiol Scand. 2003;177:17-26.
17. Yamashita H, Inenaga K, Koizumi K. Possible projections from regions of paraventricular and supraoptic nuclei to the spinal-cord - electrophysiological studies. Brain Res. 1984;296:373-378.
18. Kannan H, Hayashida Y, Yamashita H. Increase in sympathetic outflow by paraventricular nucleus stimulation in awake rats. Am J Physiol Reg Integ Comp Physiol. 1989;256:R1325-R1330.
19. Badoer E, Ng CW, De Matteo R. Tonic sympathoinhibition arising from the hypothalamic PVN in the conscious rabbit. Brain Res. 2002;947:17-24.
20. Martin DS, Segura T, Haywood JR. Cardiovascular responses to bicuculline in the paraventricular nucleus of the rat. Hypertension. 1991;18:48-55.
21. Park JB, Stern JE. A tonic, GABAA receptor-mediated inhibitory postsynaptic current restrains firing activity in preautonomic and magnocellular neuroendocrine neurons of the paraventricular nucleus of the hypothalamus (PVN). Faseb J. 2005;19:A599.
22. Li YF, Jackson KL, Stern JE, Rabeler B, Patel KP. Interaction between glutamate and GABA systems in the integration of sympathetic outflow by the paraventricular nucleus of the hypothalamus. Am J Physiol Heart Circ Physiol. 2006;291:H2847-H2856.
23. Culman J, Itoi K, Unger T. Hypothalamic tachykinins. Mediators of stress responses? Ann N Y Acad Sci. 1995;771:204-218.
24. Jessop DS, Chowdrey HS, Biswas S, Lightman SL. Substance-P and Substance-K in the Rat Hypothalamus Following Monosodium Glutamate Lesions of the Arcuate Nucleus. Neuropeptides. 1991;18:165-170.
25. Unger T, Becker H, Petty M, Demmert G, Schneider B, Ganten D, Lang RE. Differential-effects of central angiotensin-ii and substance-P on sympathetic-nerve activity in conscious rats - implications for cardiovascular adaptation to behavioral-responses. Circ Res. 1985;56:563-575.
26. Itoi K, Jost N, Badoer E, Tschope C, Culman J, Unger T. Localization of the substance P-induced cardiovascular responses in the rat hypothalamus. Brain Res. 1991;558:123-126.
27. Nakayama Y, Takano Y, Saito R, Kamiya H. Central pressor actions of tachykinin NK-3 receptor in the paraventricular nucleus of the rat hypothalamus. Brain Res. 1992;595:339-342.
28. Takano Y, Nakayama Y, Matsumoto T, Saito R, Kamiya H. The mechanism of central pressor actions of tachykinin NK-3 receptor in the paraventricular nucleus of the hypothalamus in rats. Regul Peptides. 1993;46:360-363.
29. Culman J, Klee S, Ohlendorf C, Unger T. Effect of tachykinin receptor inhibition in the brain on cardiovascular and behavioral responses to stress. J Pharmacol Exp Ther. 1997;280:238-246.
30. Paxinos G, Watson C. The Rat Brain in Stereotaxic Coordinates. Second ed. London: Academic Press Inc; 1986.
31. Laurie DJ, Wisden W, Seeburg PH. The distribution of 13 gaba-a receptor subunit messenger-RNAs in the rat-brain. 3. embryonic and postnatal-development. J Neurosci. 1992;12:4151-4172.
32. Culman J, Unger T. Central tachykinins: mediators of defence reaction and stress reactions. Can J Physiol Pharmacol. 1995;73:885-891.
33. Barrett-Jolley R, Pyner S, Coote JH. Measurement of voltage-gated potassium currents in identified spinally- projecting sympathetic neurones of the paraventricular nucleus. J Neurosci Meth. 2000;102:25-33.
34. Womack MD, Pyner S, Barrett-Jolley R. Inhibition by α-Tetra- hydrodeoxycorticosterone (THDOC) of Pre-Sympathetic Parvocellular Neurones in the Paraventricular Nucleus of Rat Hypothalamus. Br J Pharmacol. 2006;149:600-607.
35. Barrett-Jolley R. Nipecotic acid directly activates GABA(A)-like ion channels. Br J Pharmacol. 2001;133:673-678.
36. Maggi CA, Patacchini R, Feng DM, Folkers K. Activity of spantide-i and spantide-Ii at various tachykinin receptors and Nk-2 tachykinin receptor subtypes. Eur J Pharmacol. 1991;199(1):127-9.
37. Maggi CA, Giuliani S, Ballati L, Lecci A, Manzini S, Patacchini R, Renzetti AR, Rovero P, Quartara L, Giachetti A. Invivo Evidence for tachykininergic transmission using a new Nk-2 receptor-selective antagonist, men-10,376. J Pharmacol Exp Ther. 1991;257:1172-1178.
38. Sarau HM, Griswold DE, Bush B, Potts W, Sandhu P, Lundberg D, Foley JJ, Schmidt DB, Webb EF, Martin LD, Legos JJ, Whitmore RG, Barone FC, Medhurst AD, Luttmann MA, Giardina GAM, Hay DWP. nonpeptide tachykinin receptor antagonists. II. Pharmacological and pharmacokinetic profile of SB-222200, a central nervous system penetrant, potent and selective NK-3 receptor antagonist. J Pharmacol Exp Ther. 2000;295:373-381.
39. Mantyh PW, Allen CJ, Ghilardi JR, Rogers SD, Mantyh CR, Liu HT, Basbaum AI, Vigna SR, Maggio JE. Rapid endocytosis of a G-protein-coupled receptor - substance-P-evoked internalization of its receptor in the rat striatum in vivo. Proc Natl Acad Sci U S A. 1995;92:2622-2626.
40. Quartara L, Maggi CA. The tachykinin NK1 receptor. Part I: Ligands and mechanisms of cellular activation. Neuropeptides. 1997;31:537-563.
41. Brandon NJ, Delmas P, Kittler JT, McDonald BJ, Sieghart W, Brown DA, Smart TG, Moss SJ. GABAA receptor phosphorylation and functional modulation in cortical neurons by a protein kinase C-dependent pathway. J Biol Chem. 2000;275:38856-38862.
42. Yamada K, Akasu T. Substance P suppresses GABA(A) receptor function via protein kinase C in primary sensory neurones of bullfrogs. J Physiol (Lond). 1996;496:439-449.
43. Hallbeck M, Larhammar D, Blomqvist A. Neuropeptide expression in rat paraventricular hypothalamic neurons that project to the spinal cord. J Comp Neurol. 2001;433:222-238.
44. Hallbeck M, Blomqvist A. Spinal cord-projecting vasopressinergic neurons in the rat paraventricular hypothalamus. J Comp Neurol. 1999;411:201-211.
45. Malpas SC, Coote JH. Role of vasopressin in sympathetic response to paraventricular nucleus stimulation in anesthetized rats. Am J Physiol Regul Integr Comp Physiol. 1994;266:R228-R236.
46. Sawchenko PE, Swanson LW. Immunohistochemical identification of neurons in the paraventricular nucleus of the hypothalamus that project to the medulla or to the spinal-cord in the rat. J Comp Neurol. 1982;205:260-272.
47. Swanson LW, Sawchenko PE. Hypothalamic integration - organization of the paraventricular and supraoptic nuclei. Ann Rev Neurosci. 1983;6:269-324.
48. Boudaba C, Szabo K, Tasker JG. Physiological mapping of local inhibitory inputs to the hypothalamic paraventricular nucleus. J Neurosci. 1996;16:7151-7160.
49. Fenelon VS, Sieghart W, Herbison AE. Cellular localization and differential distribution of GABAA receptor subunit proteins and messenger RNAs within hypothalamic magnocellular neurons. Neurosci. 1995;64:1129-1143.
50. Hermes ML, Coderre EM, Buijs RM, Renaud LP. GABA and glutamate mediate rapid neurotransmission from suprachiasmatic nucleus to hypothalamic paraventricular nucleus in rat. J Physiol (Lond). 1996;496:749-757.
51. Tasker JG, Dudek FE. Local inhibitory synaptic inputs to neurones of the paraventricular nucleus in slices of rat hypothalamus. J Physiol (Lond). 1993;469:179-192.
52. Zaki A, Barrett-Jolley R. Rapid neuromodulation by cortisol in the rat paraventricular nucleus: an in vitro study. Br J Pharmacol. 2002;137:87-97.
53. Li DP, Chen SR, Pan HL. Nitric Oxide Inhibits Spinally projecting paraventricular neurons through potentiation of presynaptic GABA release. J Neurophysiol. 2002;88:2664-2674.
54. Badoer E, Ryan A. Effects of leptin on spinally projecting neurons in the PVN of the hypothalamus. Brain Res. 1999;844:210-215.
55. Oldfield BJ, Davern PJ, Giles ME, Allen AM, Badoer E, McKinley MJ. Efferent neural projections of angiotensin receptor (AT1) expressing neurones in the hypothalamic paraventricular nucleus of the rat. J Neuroendocrinol. 2001;13:139-146.
56. Bains JS, Potyok A, Ferguson AV. Angiotensin II actions in paraventricular nucleus: functional evidence for neurotransmitter role in efferents originating in subfornical organ. Brain Res. 1992;599:223-229.
57. Meister B, Hakansson ML. Leptin receptors in hypothalamus and circumventricular organs. Clin Exp Pharmacol Physiol. 2001;28:610-617.
58. Shirasaka T, Miyahara S, Kunitake T, Jin QH, Kato K, Takasaki M, Kannan H. Orexin depolarizes rat hypothalamic paraventricular nucleus neurons. Am J Physiol Regul Integ Comp Physiol. 2001;281:R1114-R1118.
59. Cato MJ, Toney GM. Angiotensin II excites paraventricular nucleus neurons that innervate the rostral ventrolateral medulla: An in vitro patch-clamp study in brain slices. J Neurophysiol. 2005;93:403-413.
60. Ding YQ, Shigemoto R, Takada M, Ohishi H, Nakanishi S, Mizuno N. Localization of the neuromedin K receptor (NK3) in the central nervous system of the rat. J Comp Neurol. 1996;364:290-310.
61. Koutcherov Y, Ashwell KWS, Paxinos G. The distribution of the neurokinin B receptor in the human and rat hypothalamus. Neuroreport. 2000;11:3127-3131.
62. Shults CW, Buck SH, Burcher E, Chase TN, O'Donohue TL. Distinct binding sites for substance P and neurokinin A (substance K): co-transmitters in rat brain. Peptides. 1985;6:343-345.
63. Nakajima Y, Tsuchida K, Negishi M, Ito S, Nakanishi S. Direct linkage of three tachykinin receptors to stimulation of both phosphatidylinositol hydrolysis and cyclic AMP cascades in transfected Chinese hamster ovary cells. J Biol Chem. 1992;267:2437-2442.
64. Connolly CN, Kittler JT, Thomas P, Uren JM, Brandon NJ, Smart TG, Moss SJ. Cell surface stability of gamma-aminobutyric acid type A receptors - Dependence on protein kinase C activity and subunit composition. J Biol Chem. 1999;274:36565-36572.
65. Birnir B, Eghbali M, Cox GB, Gage PW. GABA concentration sets the conductance of delayed GABA(A) channels in outside-out patches from rat hippocampal neurons. J Memb Biol. 2001;181:171-183.
66. Si JQ, Zhang ZQ, Li CX, Wang LF, Yang YL, Li ZW. Modulatory effect of substance P on GABA-activated currents from rat dorsal root ganglion. Acta Pharmacologica Sinica. 2004;25:623-629.
67. Kyrozis A, Reichling DB. Perforated-Patch Recording with Gramicidin Avoids Artifactual Changes in Intracellular Chloride Concentration. J Neurosci Meth. 1995;57:27-35.